Jeffrey Daniels - Advancing Precision Medicine Through Artificial Intelligence and Facial Analysis
With a growing database of over 10,000 diseases, FDNA's phenotyping technologies capture, structure, and interpret complex physiological information—including facial analysis— in one platform. They partner with global network of clinicians, labs, and researchers to significantly shorten the diagnostic process and advance precision medicine for patients. Jeff will enlighten us on how facial recognition technologies have evolved over the past 10 years, how FDNA is leveraging facial recognition today and how he foresees the future of precision medicine around the world.
- Jeffrey Daniels, FDNA, Senior Director, Marketing
LDV Vision Summit 2018